See Remarks · Xeris Biopharma Holdings, Inc. · Xeris Biopharma Holdings, Inc. — Stock Option (Right to Buy)
Side
M
Value
$15.76
Shares
4
Price
$3.94
Executed
Mar 12, 2026
Disclosed
Mar 16, 2026
Disclosure timeline4 days from execution to publication · legal deadline 2 business days
Mar 12 executedMar 16, 2026 disclosed
XERS · daily
Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Option exercise — administrative, little informational value
Relative size+1 / 25
$16 reported value · 0.0% of prior position
Filing timing0 / 15
Disclosed 2 business days after execution (deadline: 2)
Historical behavior+4 / 15
1 prior trade recorded in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Xeris Biopharma Holdings, Inc. — Stock Option (Right to Buy)
Ticker
XERS
Shares
4
Price per share
$3.94
Value
$15.76
Execution date (reported)
Mar 12, 2026
Owned after transaction
80.0K shares
Days from execution to publication
4
Calculation
Value = shares × reported price per share
Shares: 4
Price: $3.94
= $15.76
What this establishes
McCulloch Kevin filed this Form 4 reporting a option exercise of XERS on Mar 12, 2026. It became public on Mar 16, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
See Remarks
McCulloch Kevincik:0002031695
Issuer
Xeris Biopharma Holdings, Inc.cik:0001867096
Revision history · 0
No field has changed since this record was first ingested.
